Saturday, November 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stock Targets

Douglas Emmett, Inc Receives Upgrade from Sell to Hold Rating and Boosts Prospects with Director’s Acquisition of Shares

Roberto by Roberto
June 17, 2023
in Stock Targets
0
MYRG stock news
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

June 16, 2023 – It is a great day for Douglas Emmett, Inc (DEI) as the company received an upgrade from “sell” to “hold” rating in a recent research note issued by prominent analysts at StockNews.com. This upgrade is not only a significant milestone for the company but also marks the beginning of a new chapter in its journey towards excellence.

Douglas Emmett, Inc is a leading Real Estate Investment Trust that operates across Los Angeles and Honolulu. The company owns and manages high-quality office space and multifamily properties situated in premier coastal submarkets. Its focus on owning and acquiring top-tier office properties and premier multifamily communities has made it one of the largest owners and operators of real estate in the region.

The recent acquisition of 10,000 shares of Douglas Emmett stock by Director William E. Simon, Jr has provided an enormous boost to the company’s prospects. With his extensive experience in the field, William Simon’s investment signals confidence in the future of the company.

The acquisition was made at an average price of $12.42 per share, adding up to a total transaction value of $124,200.00. This move has further strengthened his position within the organization, with him now holding 91,000 shares valued at approximately $1,130,220.

The acquisition was disclosed to the Securities and Exchange Commission (SEC), which can be accessed through their website. It highlights that insider ownership stands at 14% following this purchase.

This development comes as no surprise given DEI’s track record for delivering value to its shareholders consistently while remaining focused on expanding its portfolio through strategic acquisitions. Over recent years they have been successful at identifying underperforming assets before optimizing them to deliver exceptional returns.

In summary, this upgrade couldn’t have come at a better time for Douglas Emmett Inc as it continues its stride towards excellence via various measures like expanding its portfolio, conducting strategic acquisitions, and fostering employees’ growth to continuously deliver value to its shareholders. William Simon’s acquisition further highlights the company’s sound financial prospects and shows that it remains an attractive investment option for discerning investors.
[bs_slider_forecast ticker=”DEI”]

Mixed Ratings for Real Estate Investment Trust Douglas Emmett with Institutional Investors Showing Faith

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”DEI” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]



Douglas Emmett, the Los Angeles-based real estate investment trust (REIT), has been the subject of several reports by equities analysts as of late. These include a recent upgrade from Piper Sandler and a downgrade from Evercore ISI.

Piper Sandler raised their rating on Douglas Emmett from “neutral” to “overweight,” while increasing their price target on the stock from $13.00 to $15.00. This move comes after the company’s share price had experienced some falls, with Wells Fargo & Company reducing their price target on DEI from $18.00 to $16.00 in March.

Evercore ISI, meanwhile, reduced its target price on DEI from $17.00 to $16.00 in March.

Despite these mixed ratings, Douglas Emmett’s consensus price target is currently at $15.78 according to data from Bloomberg.

On Friday June 16th, NYSE:DEI opened at 12.78 with a market capitalization of $2.17 billion and a P/E ratio of 25.05 alongside a beta of 0.94.

While the company’s shares have struggled recently, some institutional investors and hedge funds appear to be showing faith in Douglas Emmett’s long-term prospects by modifying their holdings in the firm.

Cibc World Markets Corp raised its position in Douglas Emmett by 0.7% during Q1 2023 while Centersquare Investment Management LLC lifted its stake by 0.3% around the same time period.

State of Alaska Department of Revenue increased its stake by 0.7% during Q4 2022 and Treasurer of the State of North Carolina added an additional 1,940 shares over a longer period.

Despite concerns about potential risks related to interest rate hikes or broader economic downturns affecting real estate markets – particularly commercial real estate – several investors remain bullish on Douglas Emmett..

Tags: DEI
Roberto

Roberto

Related Posts

RLI stock news
Stock Targets

Price T Rowe Associates Inc. Cuts Holdings in Becton, Dickinson and Company as Medical Instruments Supplier Reports Strong Quarterly Earnings

September 14, 2023
MA stock news
Stock Targets

Healthcare of Ontario Pension Plan Trust Fund Increases Holdings in Sun Life Financial Inc. and Announces Quarterly Dividend Increase

September 14, 2023
HBAN stock news
Stock Targets

Fort L.P. Reduces Holdings in A.O. Smith Co. as Industrial Products Company Shows Promising Financial Performance

September 13, 2023
Next Post
IRT stock news

Cypress Asset Management Inc. TX Reduces Stake in Diageo plc: What This Means for Investors

ANGL stock news

Rockefeller Capital Management Sells Nearly One-Third of Discover Financial Services Shares

USB stock news

Discover Financial Services Shows Strong Performance Despite Missed Earnings Estimates

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Bechtle Stock

Bechtle Stock: Mixed Q2 Results Amid Margin Pressures

3 months ago
Adobe Stock

Adobe’s AI Ambitions Meet Market Skepticism as Shares Slide

1 week ago
Commerzbank Stock

Commerzbank Deploys €1 Billion Defense Against Takeover Bid

1 month ago
EEFT stock news

Analyst Perspectives on ABM Industries Neutral Rating and Adjusted Price Targets

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

US Energy’s Pivotal Moment: Navigating Financial Headwinds with Ambitious Strategy

A Critical Year Ahead for Minerva Neurosciences

Scynexis at a Crossroads: Can a GSK Deal Reverse Its Fortunes?

Redcare Pharmacy Shares Plunge Despite Strong Fundamentals

Quantum Computing Stock Plummets Amidst Financial Turmoil

Apyx Medical Shares Surge on Strong Quarterly Results

Trending

Emergent BioSolutions Stock
Earnings

Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?

by Robert Sasse
November 8, 2025
0

Emergent BioSolutions shares have experienced significant turbulence following the company's impressive third-quarter 2025 earnings release. Despite reporting...

Trinity Biotech Stock

Trinity Biotech Shares Face Persistent Downward Pressure

November 8, 2025
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

November 8, 2025
US Energy Stock

US Energy’s Pivotal Moment: Navigating Financial Headwinds with Ambitious Strategy

November 8, 2025
Minervaeurosciences Stock

A Critical Year Ahead for Minerva Neurosciences

November 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?
  • Trinity Biotech Shares Face Persistent Downward Pressure
  • NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com